The next three weeks are among the rockiest, on a historical basis, of the entire calendar.Trading Nationread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
Microsoft is looking for a new way to grab business from retailers as they fend off Amazon.Technologyread more
The UK's Civil Aviation Authority said Thomas Cook had now ceased trading and the regulator would work with the government to bring the more than 150,000 British customers...Europe Marketsread more
Banks have historically used armies of mortgage brokers to gather income and asset documents from prospective borrowers.Financeread more
Guggenheim reiterates its buy rating on Boston Beer's stock and raises its price target to $462 from $449 per share.Investingread more
On-demand delivery company Postmates is partnering with Phantom Auto, an autonomous vehicle teleoperator, to coordinate driverless deliveries.Autosread more
Bruce Broussard, CEO of health insurance company Humana, sits down with CNBC's Bertha Coombs to discuss the state of the industry, integrating digital health technology,...Squawk Boxread more
Gluskin Sheff's David Rosenberg reinforces his recession forecast following the Federal Reserve's September meeting.Futures Nowread more
In his new memoir, "The Ride of a Lifetime," Iger explains why he decided against the deal to buy Twitter.Technologyread more
Ad-tech company The Trade Desk is launching a campaign to show how it differs from tech giants like Google and Facebook.Technologyread more
Shares of St. Jude Medical closed 0.2 percent higher, recovering earlier losses, after a temporary trading halt on Friday afternoon.
The stock fell 2.5 percent in intraday trade before the halt.
On Thursday, Muddy Waters Capital published a report announcing its short position in St. Jude. The firm alleged that the company's cardiac devices are vulnerable to cyber attacks, citing a study conducted by cybersecurity research firm MedSec.
These alleged security issues mean that "St. Jude's business faces some significant risk of recall for an extended period of time," Carson Block, founder of Muddy Waters, said in an interview on CNBC's "Closing Bell."
MedSec was unable to find encryption or authentication built into the protocol of St. Jude's devices, CEO Justine Bone said on "Closing Bell." She said that while her firm was able to find a few vulnerabilities in all the leading manufacturers of cardiac devices, the issues with St. Jude's devices were exceptional.
"St. Jude Medical really stood out as exceptionally falling far behind when it comes to their attention to the integrity and security of their product range, which is why we felt that we had to take the drastic action that we did," Bone said.
On Friday, St. Jude refuted Muddy Water and MedSec's claims, saying that while the company "would have preferred the opportunity to review a detailed account of the information, based on available information, we conclude that the report is false and misleading."
St. Jude said it is standing "behind the security and safety of our devices as confirmed by independent third parties and supported through our regulatory submissions." In particular, the company took issue with the testing methodology, saying that the report lacks detail and "includes many inconsistencies."